Clinical-Epidemiological Characteristics in Outpatients with Mild to Moderate Covid-19, in the South of Mexico City

Abstract

Background: Regional information on the characteristics of patients with mild and moderate intensity SARS-CoV-2 “COVID-19” coronavirus disease is needed to better understand the pandemic Objective: The objective of this study was to report the epidemiological clinical characteristics of outpatients with mild to moderate intensity COVID-19 that was carried out by Telemedicine in a first contact clinic, specializing in infectious diseases, in the South from Mexico City from March 10, 2020 to January 31, 2021. Material and Methods: This is a prospective, cross-sectional, observational, single-center study of a series of patients with clinical data of upper and lower respiratory tract infection and a positive CRP for SARS-CoV-2, who requested telemedicine consultation from a first contact clinic with a specialty in infectious diseases, attended from March 10, 2020 to January 31, 2021, The information was analyzed in a statistical package using SPSS 23.0. Results: 66patients who met the established criteria for diagnosis were attended to. In January 2021, the highest number of patients was treated; they requested medical attention, 6.5 days (range from 1 to 12 days) after having started with the disease. The median age was 48 years (range 10 to 80 ) years), 53% were female, 26% had type 2 diabetes mellitus, 23% with arterial hypertension, 7% previous pulmonary disease, 4% suffered from hypothyroidism, 24% positive smoking, 21% positive alcoholism, 39% had obesity , 17% were allergic. The clinical characteristics, the most prevalent was cough in 76%, followed by headache in 73% and myalgia in 71%. Conclusions: Patients with comorbidities, whether they are men or women in the fifth decade of life, are important for the evolution, especially when they are carriers of immunosenescence in the cases of those older than 60 years, or the immune system is immunocompromised as it is the case of patients with DM2 and even more so when they have more than one comorbidity that persists, they have a pro- inflammatory state and attenuation of the innate immune response.